본문 바로가기
KERD
논문KCI 등재

Antiapoptotic effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant in H9c2 rat cardiomyocytes

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

Granulocyte colony-stimulating factor (G-CSF) is used for heart failure therapy and promotes myocardial regeneration by inducing mobilization of bone marrow stem cells to the injured heart after myocardial infarction; however, this treatment has one weakness in that its biological effect is transient. In our previous report, we generated 5 mutants harboring N-linked glycosylation to improve its antiapoptotic activities. Among them, one mutant (Phe140Asn) had higher cell viability than wild-type hG-CSF in rat cardiomyocytes, even after treatment with an apoptotic agent (H2O2). Cells treated with this mutant significantly upregulated the antiapoptotic proteins, and experienced reductions in caspase 3 activity and PARP cleavage. Moreover, the total number of apoptotic cells was dramatically lower in cultures treated with mutant hG-CSF. Taken together, these results suggest that the addition of an N-linked glycosylation was successful in improving the antiapoptotic activity of hG-CSF, and that this mutated product will be a feasible therapy for patients who have experienced heart failure. [BMB Reports 2012; 45(12): 742-747]

Abstract

Granulocyte colony-stimulating factor (G-CSF) is used for heart failure therapy and promotes myocardial regeneration by inducing mobilization of bone marrow stem cells to the injured heart after myocardial infarction; however, this treatment has one weakness in that its biological effect is transient. In our previous report, we generated 5 mutants harboring N-linked glycosylation to improve its antiapoptotic activities. Among them, one mutant (Phe140Asn) had higher cell viability than wild-type hG-CSF in rat cardiomyocytes, even after treatment with an apoptotic agent (H2O2). Cells treated with this mutant significantly upregulated the antiapoptotic proteins, and experienced reductions in caspase 3 activity and PARP cleavage. Moreover, the total number of apoptotic cells was dramatically lower in cultures treated with mutant hG-CSF. Taken together, these results suggest that the addition of an N-linked glycosylation was successful in improving the antiapoptotic activity of hG-CSF, and that this mutated product will be a feasible therapy for patients who have experienced heart failure. [BMB Reports 2012; 45(12): 742-747]

참고문헌 (33)

  1. Takano, H., "Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction", J. Mol. Med., 84, pp.185~193 (2006)
  2. Minatoguchi, S., "Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment", Circulation, 109, pp.2572~2580 (2004)
  3. Orlic, D., "Mobilized bone marrow cells repair the infarcted heart, improving function and survival", Proc. Natl. Acad. Sci. U.S.A., 98, pp.10344~10349 (2001)
  4. Harada, M., "G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes", Nat. Med., 11, pp.305~311 (2005)
  5. Martin-Christin, F., "Granulocyte colony stimulating factors: how different are they? How to make a decision?", Anticancer. Drugs., 12, pp.185~191 (2001)
  6. Mallat, Z., "Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure", Circulation, 97, pp.1536~1539 (1998)
  7. Hill, M. F., "Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats", Am. J. Pathol., 148, pp.291~300 (1996)
  8. Eguchi, M., "Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis", FEBS J., 275, pp.3136~3144 (2008)
  9. Liu, J., "ERKs", p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes, 2008, pp.295, H1956~H1965
  10. Souza, L. M., "Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells", Science, 232, pp.61~65 (1986)
  11. Kubota, N., "Structural characterization of natural and recombinant human granulocyte colony-stimulating factors", J. Biochem., 107, pp.486~492 (1990)
  12. Gervais, V., "NMR investigations of the role of the sugar moiety in glycosylated recombinant human granulocyte-colony-stimulating factor", Eur. J. Biochem., 247, pp.386~395 (1997)
  13. Cumming, D. A., "Glycosylation of recombinant protein therapeutics: control and functional implications", Glycobiology, 1, pp.115~130 (1991)
  14. Hee Kyoung Chung, "Enhanced biological effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant, on HL60 cells", BMB Reports, 44(10), pp.686~691 (2011), 생화학분자생물학회
  15. Lu, H. S., "Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor", Arch. Biochem. Biophys., 268, pp.81~92 (1989)
  16. Ishikawa, M., "The substitution of cysteine 17 of recombinant human G-CSF with alanine greatly enhanced its stability", Cell Struct. Funct., 17, pp.61~65 (1992)
  17. Bishop, B., "Reengineering granulocyte colony-stimulating factor for enhanced stability", J. Biol. Chem., 276, pp.33465~33470 (2001)
  18. Tarentino, A. L., "Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F", Biochemistry, 24, pp.4665~4671 (1985)
  19. Chu, F. K., "Requirements of cleavage of high mannose oligosaccharides in glycoproteins by peptide N-glycosidase F", J. Biol. Chem., 261, pp.172~177 (1986)
  20. Umemoto, J., "Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae", J. Biol. Chem., 252, pp.8609~8614 (1977)
  21. Wang, Z., "Angiopoietin-1 protects H9c2 cells from H2O2-induced apoptosis through AKT signaling", Biochem. Biophys. Res. Commun., 359, pp.685~690 (2007)
  22. Takano, H., "G-CSF therapy for acute myocardial infarction", Trends. Pharmacol. Sci., 28, pp.512~517 (2007)
  23. Kornfeld, R., "Assembly of asparagine- linked oligosaccharides", Annu. Rev. Biochem., 54, pp.631~664 (1985)
  24. Van den Steen, P., "Concepts and principles of O-linked glycosylation", Crit. Rev. Biochem. Mol. Biol., 33, pp.151~208 (1998)
  25. Burda, P., "The dolichol pathway of N-linked glycosylation", Biochim. Biophys. Acta., 1426, pp.239~257 (1999)
  26. Munro, S., "What can yeast tell us about N-linked glycosylation in the Golgi apparatus?", FEBS Lett., 498, pp.223~227 (2001)
  27. Oheda, M., "Structures of the sugar chains of recombinant human granulocyte- colony-stimulating factor produced by Chinese hamster ovary cells", J. Biochem., 103, pp.544~546 (1988)
  28. Clogston, C. L., "Glycosidase digestion, electrophoresis and chromatographic analysis of recombinant human granulocyte colony-stimulating factor glycoforms produced in Chinese hamster ovary cells", J. Chromatogr., 637, pp.55~62 (1993)
  29. Tamada, T., "Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex", Proc. Natl. Acad. Sci. U.S.A., 103, pp.3135~3140 (2006)
  30. Okazaki, T., "Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes", Am. J. Pathol., 171, pp.1093~1103 (2007)
  31. Pacher, P., "Role of poly(ADP-ribose) polymerase1 (PARP-1) in cardiovascular diseases: the therapeuticpotential of PARP inhibitors", Cardiovasc. Drug. Rev., 25, pp.235~260 (2007)
  32. Ungvari, Z., "Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure", Curr. Vasc. Pharmacol., 3, pp.221~229 (2005)
  33. Pacher, P., "Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure", J. Pharmacol. Exp. Ther., 300, pp.862~867 (2002)

관련 논문AI추천

Enhanced biological effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant, on HL60 cells권무식, 김경운, 박수봉, 유재규, 정학재, Byoung-Chul Yang, Eun Mi Ko, Hee Kyoung Chung, Hwi-Cheul Lee, Jae-Seok Woo, Jin-Ki Park, Sung June Byun, Sung Woo Kim생화학분자생물학회 · BMB Reports2011 · 제44권 제10호Effects of Granulocyte-Colony Stimulating Factor and Bone Marrow Mononuclear Cells on Cardiac Function and Remodeling in the Porcine Reperfused Myocardial Infarction Model김정향, 노영무, 박미영, 방영호, 신성희, 심완주, 임도선, 최승철, 홍순준한국심초음파학회 · Journal of Cardiovascular Imaging2009 · 제17권 제2호Granulocyte Colony Stimulating Factor Attenuates Hyperoxia-Induced Lung Injury by Down-Modulating Inflammatory Responses in Neonatal Rats구수현, 성동경, 신종범, 장윤실, 정유진, 최서희, Ga Won Jeon, Won Soon Park연세대학교의과대학 · Yonsei Medical Journal2011 · 제52권 제1호Secretion of Biologically Active Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor by Transduced Gastric Cancer Cells박선, 김경민, 김형일, 김희영, 박길순, 신호준연세대학교의과대학 · Yonsei Medical Journal2008 · 제49권 제2호대장균에서 증식속도 조절에 의한 수용성 재조합 인간 과립구 콜로니 촉진인자의 생산강희일, 고인영, 박세철한국미생물·생명공학회 · 한국미생물·생명공학회지2004 · 제32권 제2호시험관내허혈환경에서과립구성장인자의인간뇌피질에서유래된신경세포주의보호효과정근화대한뇌졸중학회 · 대한뇌졸중영문학회지2004 · 제6권 제1호

이 간행물의 다른 논문 (11건)